Analytic Investors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | $100M | Buy |
1,861,534
+362,268
| +24% | +$19.5M | 1.12% | 22 |
|
|
2016
Q2 | $110M | Buy |
1,499,266
+245,961
| +20% | +$18.1M | 1.3% | 18 |
|
|
2016
Q1 | $80.1M | Buy |
1,253,305
+656,906
| +110% | +$42M | 0.98% | 25 |
|
|
2015
Q4 | $41M | Buy |
596,399
+279,751
| +88% | +$19.2M | 0.51% | 52 |
|
|
2015
Q3 | $18.7M | Sell |
316,648
-1,485
| -0.5% | -$87.9K | 0.25% | 96 |
|
|
2015
Q2 | $21.2M | Buy |
318,133
+310,041
| +3,831% | +$20.6M | 0.3% | 84 |
|
|
2015
Q1 | $522K | Sell |
8,092
-9,725
| -55% | -$627K | 0.01% | 441 |
|
|
2014
Q4 | $1.05M | Buy |
+17,817
| New | +$1.05M | 0.01% | 347 |
|
|
2013
Q4 | – | Sell |
-5,079
| Closed | -$235K | – | 506 |
|
|
2013
Q3 | $235K | Buy |
+5,079
| New | +$235K | ﹤0.01% | 469 |
|